Quoin Pharmaceuticals, Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-7.64-31.776.903.06
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-0.93$-0.22$1.03$2.33

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.590.913.850.88-3.02-14.71-0.84-0.74-0.50-0.08-1.55
Price/Sales ratio
N/A-50.28N/A-48.53N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
0.571.907.213.641.09-3.9210.970.920.780.14-1.41
Price/Cash Flow ratio
-0.78-3.73-7.87-2.06-3.63-19.38-1.26-0.81-0.56-0.16-2.85
Price/Free Cash Flow ratio
-0.74-3.43-7.75-2.01-3.32-17.73-1.13-0.78-0.56-0.15-2.66
Price/Earnings Growth ratio
N/A-0.00-0.080.020.020.18-0.000.000.00-0.000.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A948.33%N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A131.83%N/A144.9%N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/A-5470.35%N/A-5470.35%N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/A-5470.35%N/A-5470.35%N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/A-5470.35%N/A-5470.35%N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A0.96%-11.46%-1.05%-99.35%15.81%60.30%1.10%-0.25%N/A-50.20%
Return on Assets
-76.23%173.84%116.26%277.33%-25.27%-128.03%-91.04%-64.16%-71.38%-93.50%-76.65%
Return On Equity
-96.99%206.93%187.31%411.08%-36.32%26.69%-1296.53%-125.25%-153.36%1899.73%187.38%
Return on Capital Employed
-96.28%193.75%134.40%363.65%-30.47%31.00%-3100.63%-80.95%-109.20%-57.62%0.26%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A3.79N/A
Quick Ratio
4.249.296.963.805.110.050.973.793.153.644.37
Cash ratio
1.361.803.353.634.980.040.860.810.670.812.51
Days of Sales Outstanding
N/A-224.22N/A-75.35N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A0.000.00N/A0.00N/AN/AN/AN/AN/A0.00
Operating Cycle
N/A-224.21N/A-75.35N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
2.39K1.42K1.71K689.1573.53N/A3.23K2.13K1.85KN/A36.76
Cash Conversion Cycle
N/A-1.65KN/A-764.50N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.00N/AN/A0.010.8879.93N/AN/A0.480.00
Debt Equity Ratio
N/A0.00N/AN/A0.02-0.181.13KN/AN/A0.950.01
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.86N/AN/AN/AN/A
Total Debt to Capitalization
N/A0.00N/AN/A0.02-0.220.99N/AN/AN/A-0.09
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-6.54N/A
Cash Flow to Debt Ratio
N/A-249.96N/AN/A-11.32-1.10-0.00N/AN/AN/A-5.66
Company Equity Multiplier
1.271.191.611.481.43-0.2014.241.952.141.951.45
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A13.45N/A23.47N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.041.081.011.021.091.091.101.0211.061.09
Cash Flow Coverage Ratio
N/A-249.96N/AN/A-11.32-1.10-0.00N/AN/AN/A-5.66
Short Term Coverage Ratio
N/A-249.96N/AN/A-11.32-1.10-0.00N/AN/AN/A-5.66
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-703.49%N/AN/AN/A